Fig. 3From: Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA–IIA non-small cell lung cancer, a retrospective cohort studya OS for patients with 0–5 and more than 5 N1 LNs examined patients. b DFS for patients with 0–5 and more than 5 N1 N1 LNs examined patients. c Five-year DFS for patients with 0–5 and more than 5 N1 LNs examined patientsBack to article page